AGL 6.90 Increased By ▲ 0.45 (6.98%)
ANL 9.77 Increased By ▲ 0.07 (0.72%)
AVN 76.82 Decreased By ▼ -0.78 (-1.01%)
BOP 5.49 Increased By ▲ 0.06 (1.1%)
CNERGY 5.05 Increased By ▲ 0.08 (1.61%)
EFERT 79.83 Increased By ▲ 2.58 (3.34%)
EPCL 57.48 Increased By ▲ 1.99 (3.59%)
FCCL 15.30 Decreased By ▼ -0.06 (-0.39%)
FFL 6.48 No Change ▼ 0.00 (0%)
FLYNG 7.34 Decreased By ▼ -0.13 (-1.74%)
GGGL 10.75 Increased By ▲ 0.30 (2.87%)
GGL 16.94 Increased By ▲ 0.55 (3.36%)
GTECH 8.30 Decreased By ▼ -0.07 (-0.84%)
HUMNL 6.45 No Change ▼ 0.00 (0%)
KEL 3.02 Increased By ▲ 0.09 (3.07%)
LOTCHEM 29.15 Increased By ▲ 0.81 (2.86%)
MLCF 28.30 Increased By ▲ 0.22 (0.78%)
OGDC 76.53 Increased By ▲ 2.68 (3.63%)
PAEL 15.87 Increased By ▲ 0.32 (2.06%)
PIBTL 5.43 Increased By ▲ 0.08 (1.5%)
PRL 17.69 Increased By ▲ 0.30 (1.73%)
SILK 1.08 Increased By ▲ 0.01 (0.93%)
TELE 10.82 Decreased By ▼ -0.14 (-1.28%)
TPL 8.60 Increased By ▲ 0.79 (10.12%)
TPLP 21.19 Increased By ▲ 1.53 (7.78%)
TREET 23.80 Decreased By ▼ -0.05 (-0.21%)
TRG 127.50 Increased By ▲ 0.60 (0.47%)
UNITY 23.10 Increased By ▲ 0.04 (0.17%)
WAVES 11.63 Increased By ▲ 0.08 (0.69%)
WTL 1.14 No Change ▼ 0.00 (0%)
BR100 4,174 Increased By 48.3 (1.17%)
BR30 15,806 Increased By 310.9 (2.01%)
KSE100 41,518 Increased By 366.7 (0.89%)
KSE30 15,562 Increased By 142.1 (0.92%)
World

Brazil green-lights Pfizer vaccine for kids 12 and up

  • The health regulator, Anvisa, said the approval was based on studies by Pfizer that "indicated the vaccine's safety and effectiveness for this age group."
Published June 11, 2021
Follow us

SAO PAULO: Brazil's health regulator approved the Pfizer Covid-19 vaccine Friday for use in children aged 12 and up, though they will likely have to wait months in line for older age groups to be vaccinated first.

Hit hard by the pandemic, Brazil joins countries including the United States, Uruguay and Chile in extending vaccination to minors.

However, supply issues mean the move is mainly symbolic for now.

Brazil's Covid-19 vaccination drive, which began in January, has been hit by shortages and delays.

Around 11 percent of the country's 212 million people have been fully vaccinated so far.

Cities such as Sao Paulo and Rio de Janeiro have only recently finished vaccinating priority groups such as health workers and the elderly.

They are now vaccinating the general population in descending order by age, and are currently immunizing people in their 50s.

The health regulator, Anvisa, said the approval was based on studies by Pfizer that "indicated the vaccine's safety and effectiveness for this age group."

In addition to the US pharmaceutical giant's vaccine, developed with German firm BioNTech, Brazil is currently using the Oxford/AstraZeneca vaccine and Chinese-developed CoronaVac.

Regulators have also approved the Johnson & Johnson vaccine, but the government has not yet reached a deal to purchase it.

Brazil has struggled to source enough vaccine doses.

Far-right President Jair Bolsonaro faces criticism for refusing offers of vaccines last year, including from Pfizer, and instead pushing the ineffective medication chloroquine against Covid-19.

The pandemic has claimed more than 480,000 lives in Brazil, second only to the United States.

Comments

Comments are closed.